Skip to content

Canceled by the investigator Lipi Guben Decoction in Treating Diarrheal Irritable Bowel Syndrome: a study protocol for a randomized controlled trial

Lipi Guben Decoction in Treating Diarrheal Irritable Bowel Syndrome: a study protocol for a randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039617
Enrollment
Unknown
Registered
2020-11-03
Start date
2020-12-15
Completion date
Unknown
Last updated
2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel syndrome

Interventions

Sponsors

The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. According to the IBS diagnostic criteria of Western medicine, the patients with diarrhea as the main type and the patients with liver depression and spleen deficiency syndrome, spleen stomach weakness syndrome and liver depression and qi stagnation syndrome of traditional Chinese medicine. 2. Patients willing to sign informed consent. 3. Patients aged from 18 to 65 years.

Exclusion criteria

Exclusion criteria: 1. Pregnant or preparing for pregnancy, lactating women. 2. Patients with intestinal organic diseases, such as inflammatory bowel disease, intestinal tuberculosis and colonic polyps; 3. Patients with severe diseases of cardiovascular and cerebrovascular system, liver, kidney, hematopoietic system and tumors; 4. Patients with digestive tract operation records; 5. Patients with serious primary diseases and psychosis; 6. Patients with allergic history or drug and food allergy during the test period; 7. Patients who did not meet the inclusion criteria, did not use drugs according to the regulations, could not judge the efficacy or incomplete information, which affected the efficacy or safety judgment. 8. Patients considered unsuitable for this clinical trial.

Design outcomes

Primary

MeasureTime frame
TCM syndrome curative effect;

Secondary

MeasureTime frame
Quality of Life Questionnaire (IBS-QOL);IBS symptom severity scale;

Countries

China

Contacts

Public ContactYang Hongmei

The First Affiliated Hospital of Guizhou University of traditional Chinese Medicine

2241159873@qq.com+86 17322011794

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 24, 2026